ENTITY

Tg Therapeutics (TGTX US)

3
Analysis
Health Care • United States
TG Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of innovative pharmaceutical products for the treatment of cancer and other underserved therapeutic needs. Currently, the company is developing two therapies targeting hematological malignancies, specifically, relapsed and refractory non-Hodgkins lymphoma.
more
Company Event • 02 Nov 2026 21:30 • Upcoming
Add To Calendar

Q3 2026

Company Event • 15 Sep 2026 00:00 • Latest

H.C. Wainwright 28th Annual Global Investment Conference

Company Event • 09 Sep 2026 23:30

12th Annual Cantor Fitzgerald Global Healthcare Conference

Company Event • 13 Aug 2026 00:30

Canaccord Genuity's 46th Annual Growth Conference

Company Event • 03 Aug 2026 20:30

Q2 2026

x